Sana Biotechnology, Inc. (SANA) Misses Q4 EPS by 7c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q4 EPS of ($0.21), $0.07 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Lifetime Brands closes $60M term loan and extends $200M credit facility
• AdvanSix refinances credit facility with $425M in new debt